Role of baseline parameters in determining indirect pharmacodynamic responses

被引:13
作者
Sun, YN [1 ]
Jusko, WJ [1 ]
机构
[1] SUNY Buffalo, Sch Pharm, Dept Pharmaceut, Buffalo, NY 14260 USA
关键词
D O I
10.1021/js9901155
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Indirect Response Models account for the pharmacodynamics of numerous drugs which inhibit or stimulate the production (k(in)) or loss (k(out)) of the response variable (R). The dose and pharmacokinetics, capacity (S-max, /(max)), and potency (SC50, IC50) factors of the Hill function incorporated in these models are the primary determinants of overall responsiveness. However, the initial or baseline value for the response (R-0 = k(in)/K-out) should also be considered as an important factor for the net response. Using Indirect Response Model III (stimulation of input) as an example, the net area under the effect curve (AUEC(NET)) can be proportional to the R-0 values. Such a feature is demonstrated in this report by computer simulations, by examination of the integral of the simulated response vs time profiles, and with examples from the literature. Also shown is an adjustment of R-0 when the therapeutic agent is an endogenous substance. These analyses show that the role of R-0 and k(in) should not be overlooked as determinants of indirect responses and source of variation among subjects or patient groups.
引用
收藏
页码:987 / 990
页数:4
相关论文
共 9 条
[1]   Comparison of a direct and indirect population pharmacodynamic model: Application to recombinant human erythropoietin in athletes [J].
Bressolle, F ;
Audran, M ;
Gareau, R ;
Pham, TN ;
Gomeni, R .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1997, 25 (03) :263-275
[2]   Pharmacoimmunodynamic interactions of interleukin-10 and prednisone in healthy volunteers [J].
Chakraborty, A ;
Blum, RA ;
Cutler, DL ;
Jusko, WJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (03) :304-318
[3]  
D'Argenio DZ, 1997, ADAPT 2 USERS GUIDE
[4]   COMPARISON OF 4 BASIC MODELS OF INDIRECT PHARMACODYNAMIC RESPONSES [J].
DAYNEKA, NL ;
GARG, V ;
JUSKO, WJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1993, 21 (04) :457-478
[5]   THE MOLECULAR MECHANISM OF ERYTHROPOIETIN ACTION [J].
KOURY, MJ ;
BONDURANT, MC .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 210 (03) :649-663
[6]   Integrated functions for four basic models of indirect pharmacodynamic response [J].
Krzyzanski, W ;
Jusko, WJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (01) :67-72
[7]   Use of an indirect pharmacodynamic stimulation model of MX protein induction to compare in vivo activity of interferon alfa-2a and a polyethylene glycol-modified derivative in healthy subjects [J].
Nieforth, KA ;
Nadeau, R ;
Patel, IH ;
Mould, D .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (06) :636-646
[8]   Characterization of four basic models of indirect pharmacodynamic responses [J].
Sharma, A ;
Jusko, WJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1996, 24 (06) :611-635
[9]  
Sun YN, 1999, J PHARMACOL EXP THER, V289, P1523